CHICAGO, Oct. 20, 2022 (GLOBE NEWSWIRE) -- A Qualitative Research Study accomplished by Data Bridge Market research's database, titled “Chronic Disease Management Market” with 100+ market data Tables, Pie Charts, Graphs & Figures spread through Pages and easy-to-understand detailed analysis. The Chronic Disease Management market research report is absolutely fair and clear research report designed by masters by using top-notch research techniques and tools. SWOT Analysis and Porter’s Five Forces analysis helps to find out the threats, opportunities, strength, and weakness present in the Chronic Disease Management market. The report is a careful examination of the Chronic Disease Management market and gives bits of knowledge about noteworthy techniques, scope, chronicled data, and accurate data of the general market. It moreover joins foreseen bits of knowledge that are evaluated with the assistance of a sensible game plan of frameworks and speculations
Data Bridge Market Research analyses that the chronic disease management market was valued at USD 6.17 billion in 2021 and is expected to reach USD 20.64 billion by 2029, registering a CAGR of 16.3% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Get a Sample Copy of the Chronic Disease Management Market Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-chronic-disease-management-market
Chronic disease management (CDM) is a type of long-term care and support that provides people with a chronic illness with the medical treatment, knowledge, skills, and resources they need to manage their condition on a daily basis better. Various software and services are mostly responsible for it. By avoiding or decreasing the consequences of the disease through integrated care, chronic disease management aids in lowering healthcare expenditures and enhancing the quality of life for those with chronic illnesses.
Globally, chronic diseases are the primary cause of mortality and disability. Chronic diseases account for about 60% of deaths and 43% of global disease burden, according to the WHO's global status report on non-communicable diseases 2010. Chronic diseases are long-term progressive ailments that are among the most expensive and common healthcare challenges in the world. Chronic disease management is a sort of digital healthcare service that assists healthcare providers in providing educational information to their patients and the implementation of patient- and illness-specific treatment alternatives and regimens. These services are specifically developed to help people manage chronic conditions and lessen their severity.
Recent Development
- In April 2021, WellSky had announced the launch of an advanced home health visit management solution. CareInsights Guidance is a new component that gives actionable visit utilization insights to help balance treatment quality and patient health improvement. It is expected that the debut of this solution will help their patients and employees and boost the company's sales growth.
Some of the major players operating in the Chronic Disease Management market are:
- WellSky (US)
- ZeOmega (India)
- Health Catalyst (US)
- Cedar Gate Technologies (US)
- Cognizant (US)
- Pegasystems Inc. (US)
- Epic Systems Corporation (US)
- Hinduja Global Solutions Ltd. (Bengaluru)
- NXGN Management, LLC (US)
- MINES & Associates, Inc. (US)
- Casenet, LLC (US)
- ExlServings Holdings, Inc. (US)
- cliexa, Inc. (Colorado)
- ScienceSoft USA Corporation (US)
- Vivify Health, Inc. (Texas)
- Allscripts Healthcare, LLC (US)
- Infosys Limited (Bengaluru)
- Medecision (US)
- IBM (US)
- Altruista Health (US)
- TCS Healthcare Technologies (US)
- Koninklijke Philips N.V. (Netherlands)
Get a Detailed Research Report to Know More @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-chronic-disease-management-market
Technological advancement
Moreover, the rising adoption rate of advanced technologies will provide beneficial opportunities for the chronic disease management market growth. The rising adoption of health information technologies and the many online resource options available in healthcare are boosting the chronic disease management industry
Moreover, growing number of service providers and increase in the number of emerging markets will further provide beneficial opportunities for the chronic disease management market growth during the forecast period.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the Chronic Disease Management market
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, and geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Chronic Disease Management Market
Market Drivers:
- Increasing prevalence of chronic diseases
The rising prevalence of chronic diseases such as diabetes, high blood pressure, cancer, and others will propel the market's growth rate during the forecast period of 2022-2029. Chronic diseases are a major source of concern among the elderly, who are more prone to obesity and diabetes.
- Rise in the number of geriatric population
The number of persons aged 60 and up has consistently increased over time as a result of rising life expectancy. The worldwide geriatric population will grow from 727 million in 2020 to 1.5 billion by 2050, according to the United Nations Database on World Population Ageing 2020. Geriatric people have the highest risk of suffering from chronic diseases, increasing the demand for the chronic disease management market.
Furthermore, the rise in sedentary lifestyle will act as major factor influencing the growth of chronic disease management market. Along with this, increasing urbanization and rising disposable income are the driving factors accelerating the growth of the chronic disease management market. Also, increasing expenditure on healthcare infrastructure will escalate the growth of chronic disease management market
To Gain More Insights about this Research, Visit @ https://www.databridgemarketresearch.com/reports/global-chronic-disease-management-market
Key Industry Segmentation: Chronic Disease Management Market
The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications
By Type
- Solution
- Services
By Solution Type
- On-Premise Solution
- Cloud-Based Solution
- Web-Based
By Service Type
- Educational Service
- Implementation Service
- Consulting Service
By Disease Indication
- Cardiovascular Diseases (CVD)
- Diabetes
- Chronic Obstructive Pulmonary Disorders (COPD)
- Arthritis
- Asthma
- Cancer
By End User
- Healthcare Providers
- Healthcare Payers
Regional Analysis/Insights: Chronic Disease Management Market
The countries covered in the chronic disease management market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the chronic disease management market because of the increasing number of geriatric population and the development of advanced technology in this region. Additionally, growing presence of major market players will flourish the market's growth rate in this region.
Asia-Pacific is expected to grow during the forecast period of 2022 to 2029 due to the rising presence of chronic diseases management providers.
Table of Contents:
- Introduction
- Market Segmentation
- Executive Summary
- Premium Insights
- Global Chronic Disease Management Market Regulations
- Market Overview
- Global Chronic Disease Management Market, By Type
- Global Chronic Disease Management Market, Solution Type
- Global Chronic Disease Management Market, By Service Type
- Global Chronic Disease Management Market, By Disease Indication
- Global Chronic Disease Management Market, By End User
- Global Chronic Disease Management Market, By Region
- Global Chronic Disease Management Market: Company Landscape
- SWOT Analyses
- Company Profile
- Questionnaires
- Related Reports
To Check the Complete Table Of contents, click here @ https://www.databridgemarketresearch.com/toc/?dbmr=global-chronic-disease-management-market
Explore More Reports:-
- Europe Chronic Disease Management Market, By Type (Solution and Services), Solution Type (On-Premise Solution, Cloud-Based Solution, Web-Based), Service Type (Educational Service, Implementation Service, Consulting Service and Others), Disease indication (Cardiovascular Diseases (CVD), Diabetes, Chronic Obstructive Pulmonary Disorders (COPD), Arthritis, Asthma, Cancer and Others), End User (Healthcare Providers, Healthcare Payers, Others), Country (U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Ireland, Rest Of Europe ) https://www.databridgemarketresearch.com/reports/europe-chronic-disease-management-market
- Asia Pacific Chronic Disease Management Market, By Type (Solution and Services), Solution Type (On-Premise Solution, Cloud-Based Solution, Web-Based), Service Type (Educational Service, Implementation Service, Consulting Service and Others), Disease Type (Cardiovascular Diseases (CVD), Diabetes, Chronic Obstructive Pulmonary Disorders (COPD), Arthritis, Asthma, Cancer and Others), End User (Healthcare Providers, Healthcare Payers, Others), Country (China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific) https://www.databridgemarketresearch.com/reports/asia-pacific-chronic-disease-management-market
- North America Chronic Disease Management Market, By Type (Solution and Services), Solution Type (On-Premise Solution, Cloud-Based Solution, Web-Based), Service Type (Educational Service, Implementation Service, Consulting Service and Others), Disease indication (Cardiovascular Diseases (CVD), Diabetes, Chronic Obstructive Pulmonary Disorders (COPD), Arthritis, Asthma, Cancer and Others), End User (Healthcare Providers, Healthcare Payers, Others), Country (U.S., Canada, Mexico) https://www.databridgemarketresearch.com/reports/north-america-chronic-disease-management-market
- Middle East and Africa Chronic Disease Management Market, By Type (Solution and Services), Solution Type (On-Premise Solution, Cloud-Based Solution, Web-Based), Service Type (Educational Service, Implementation Service, Consulting Service and Others), Disease indication (Cardiovascular Diseases (CVD), Diabetes, Chronic Obstructive Pulmonary Disorders (COPD), Arthritis, Asthma, Cancer and Others), End User (Healthcare Providers, Healthcare Payers, Others), Country (Saudi Arabia, South Africa, UAE, Israel, Egypt and Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/middle-east-and-africa-chronic-disease-management-market
- Chronic Disease Management Technology Market, By Delivery Mode (Cloud-Based and On-Premises), Services (Educational Service, Implementation Service, Consulting Service and Others), Disease Type (Cardiovascular Diseases (CVD), Diabetes, Arthritis, Asthma, Diabetes, Cancer and Others), End User (Healthcare Providers, Healthcare Payers, Others) https://www.databridgemarketresearch.com/reports/global-chronic-disease-management-technology-market
- Chronic Lymphocytic Leukemia Therapeutics Market, By Treatment Type (Chemotherapy, Targeted Therapy, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-chronic-lymphocytic-leukemia-therapeutics-market
- Chronic Kidney Disease (CKD) Market, By Product Type (Diagnosis, Treatment), Route of Administration (Oral, Intravenous, Subcutaneous), End Users (Hospitals, Diagnostic Laboratories, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-chronic-kidney-disease-ckd-market
- Chronic Disease Management Market, By Type (Solution, Services), Solution Type (On-Premise Solution, Cloud-Based Solution, Web-Based), Service Type (Educational Service, Implementation Service, Consulting Service and Others), Disease Indication (Cardiovascular Diseases (CVD), Diabetes, Chronic Obstructive Pulmonary Disorders (COPD), Arthritis, Asthma, Cancer, Others), End User (Healthcare Providers, Healthcare Payers, Others) https://www.databridgemarketresearch.com/reports/global-chronic-disease-management-market
- Chronic Obstructive Pulmonary Disease (COPD) Drug Market, By Drug Type (Phosphodiestrase-4 Inhibitors, Long-Acting Bronchodilators, Short-Acting Bronchodilators, Methylxanthines, Corticosteroids), Product Type (Inhalers, Nebulizers), Type (Chronic Bronchitis, Emphysema), Diagnosis (Pirometry, Diagnostic Tests, Others), Treatment (Oxygen Therapy, Lung Transplant, Drug Therapy, Vaccination, Surgery, Others), End User (Hospitals & Clinics, Home Care Settings, Others), Country https://www.databridgemarketresearch.com/reports/global-chronic-obstructive-pulmonary-disease-copd-drug-market
- Chronic Fatigue Syndrome Market, By Type (Immune Enhancer & Antivirals, Sleep Enhancing, CNS Stimulants, Others), End-User (Hospitals, Clinics, Research Institutes), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-chronic-fatigue-syndrome-market
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com
